114 related articles for article (PubMed ID: 15918510)
1. Synthesis of 3-alkylthio-6-allylthiopyridazine derivatives and their antihepatocarcinoma activity.
Kwon SK; Moon A
Arch Pharm Res; 2005 Apr; 28(4):391-4. PubMed ID: 15918510
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive allylthiopyridazines inhibit invasion, migration and angiogenesis in hepatocarcinoma cells.
Lee EJ; Shin I; Kwon SK; Shin HS; Moon A
Int J Oncol; 2003 Dec; 23(6):1645-50. PubMed ID: 14612936
[TBL] [Abstract][Full Text] [Related]
3. Chemopreventive allylthiopyridazine derivatives induce apoptosis in SK-Hep-1 hepatocarcinoma cells through a caspase-3-dependent mechanism.
Jung MY; Kwon SK; Moon A
Eur J Cancer; 2001 Nov; 37(16):2104-10. PubMed ID: 11597391
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of allylthiopyridazine derivatives and inhibition of aflatoxin B1-induced hepatotoxicity in rats.
Shin HS; Kwon SK
Arch Pharm Res; 2003 May; 26(5):351-7. PubMed ID: 12785730
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activities of new 3-allylthio-6-(mono or disubstituted)aminopyridazines.
Won YH; Park MS
Arch Pharm Res; 2010 Feb; 33(2):189-96. PubMed ID: 20195817
[TBL] [Abstract][Full Text] [Related]
6. Discovery and synthesis of novel allylthioaralkylthiopyridazines: their antiproliferative activity against MCF-7 and Hep3B cells.
Park HS; Kim C; Park MS
Arch Pharm Res; 2015; 38(5):791-800. PubMed ID: 24925344
[TBL] [Abstract][Full Text] [Related]
7. Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors.
Kim EY; Kang ST; Jung H; Park CH; Yun CS; Hwang JY; Byun BJ; Lee CO; Kim HR; Ha JD; Ryu DH; Cho SY
Arch Pharm Res; 2016 Apr; 39(4):453-464. PubMed ID: 26753914
[TBL] [Abstract][Full Text] [Related]
8. 3-[(6-Arylamino)pyridazinylamino]benzoic acids: design, synthesis and in vitro evaluation of anticancer activity.
Abouzid KA; Khalil NA; Ahmed EM; Mohamed KO
Arch Pharm Res; 2013 Jan; 36(1):41-50. PubMed ID: 23307426
[TBL] [Abstract][Full Text] [Related]
9. Discovery of imidazo[1,2-b]pyridazine derivatives: selective and orally available Mps1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activity.
Kusakabe K; Ide N; Daigo Y; Itoh T; Yamamoto T; Hashizume H; Nozu K; Yoshida H; Tadano G; Tagashira S; Higashino K; Okano Y; Sato Y; Inoue M; Iguchi M; Kanazawa T; Ishioka Y; Dohi K; Kido Y; Sakamoto S; Ando S; Maeda M; Higaki M; Baba Y; Nakamura Y
J Med Chem; 2015 Feb; 58(4):1760-75. PubMed ID: 25625617
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxic activities of pyrrole[2,3-d]pyridazin-4-one derivatives.
Murineddu G; Cignarella G; Chelucci G; Loriga G; Pinna GA
Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):754-9. PubMed ID: 12045328
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in-vitro cytotoxic evaluation of novel pyridazin-4-one derivatives.
Mojahidi S; Rakib el M; Sekkak H; Abouricha S; Benchat N; Mousse HA; Zyad A
Arch Pharm (Weinheim); 2010 May; 343(5):310-3. PubMed ID: 20222064
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxic activities of some pyrazoline derivatives bearing phenyl pyridazine core as new apoptosis inducers.
George RF; Fouad MA; Gomaa IEO
Eur J Med Chem; 2016 Apr; 112():48-59. PubMed ID: 26874744
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular modelling and anticancer evaluation of new pyrrolo[1,2-b]pyridazine and pyrrolo[2,1-a]phthalazine derivatives.
Popovici L; Amarandi RM; Mangalagiu II; Mangalagiu V; Danac R
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):230-243. PubMed ID: 30734610
[TBL] [Abstract][Full Text] [Related]
14. Design and Synthesis of Pyridazine Containing Compounds with Promising Anticancer Activity.
Elmeligie S; Ahmed EM; Abuel-Maaty SM; Zaitone SA; Mikhail DS
Chem Pharm Bull (Tokyo); 2017; 65(3):236-247. PubMed ID: 28250345
[TBL] [Abstract][Full Text] [Related]
15. In vitro cytostatic activity of 1,2,4-triazolo- and 1,2,3,4-tetrazolo pyridazines.
Hładoń B; Laskowska H; Sloderbach A; Melzer E
Pol J Pharmacol; 1997; 49(6):471-7. PubMed ID: 9566051
[TBL] [Abstract][Full Text] [Related]
16. Thiazolo[4,5-d]pyridazine analogues as a new class of dihydrofolate reductase (DHFR) inhibitors: Synthesis, biological evaluation and molecular modeling study.
Ewida MA; Abou El Ella DA; Lasheen DS; Ewida HA; El-Gazzar YI; El-Subbagh HI
Bioorg Chem; 2017 Oct; 74():228-237. PubMed ID: 28865294
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY
Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure and cytotoxicity of 3-C, N, S, Se substituted benzo[b]selenophene derivatives.
Arsenyan P; Paegle E; Belyakov S; Shestakova I; Jaschenko E; Domracheva I; Popelis J
Eur J Med Chem; 2011 Aug; 46(8):3434-43. PubMed ID: 21621884
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro biological evaluation of thiosulfinate derivatives for the treatment of human multidrug-resistant breast cancer.
Roseblade A; Ung A; Bebawy M
Acta Pharmacol Sin; 2017 Oct; 38(10):1353-1368. PubMed ID: 28858299
[TBL] [Abstract][Full Text] [Related]
20. Pyridazinone derivatives displaying highly potent and selective inhibitory activities against c-Met tyrosine kinase.
Liu Y; Jin S; Peng X; Lu D; Zeng L; Sun Y; Ai J; Geng M; Hu Y
Eur J Med Chem; 2016 Jan; 108():322-333. PubMed ID: 26698536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
